185 related articles for article (PubMed ID: 30974737)
1. Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents.
Yang XG; Mou YH; Wang YJ; Wang J; Li YY; Kong RH; Ding M; Wang D; Guo C
Molecules; 2019 Apr; 24(7):. PubMed ID: 30974737
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
Lv Q; Yang X; Wang M; Yang J; Qin Z; Kan Q; Zhang H; Wang Y; Wang D; He Z
J Control Release; 2018 Jun; 279():234-242. PubMed ID: 29679664
[TBL] [Abstract][Full Text] [Related]
3. Application of novel pH sensitive isoniazid-heptamethine carbocyanine dye conjugates against prostate cancer cells.
Yang XG; Li YF; Wang YJ; Kong RH; Wang D
Pharmazie; 2020 Sep; 75(9):412-416. PubMed ID: 32797765
[TBL] [Abstract][Full Text] [Related]
4. Repurposing antitubercular agent isoniazid for treatment of prostate cancer.
Lv Q; Wang D; Yang Z; Yang J; Zhang R; Yang X; Wang M; Wang Y
Biomater Sci; 2018 Dec; 7(1):296-306. PubMed ID: 30468220
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of a monoamine oxidase A inhibitor‑heptamethine carbocyanine dye conjugate for paclitaxel‑resistant non‑small cell lung cancer.
Yang XG; Li YY; Zhao DX; Cui W; Li H; Li XY; Li YX; Wang D
Oncol Rep; 2021 Mar; 45(3):1306-1314. PubMed ID: 33650669
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.
Wu JB; Lin TP; Gallagher JD; Kushal S; Chung LW; Zhau HE; Olenyuk BZ; Shih JC
J Am Chem Soc; 2015 Feb; 137(6):2366-74. PubMed ID: 25585152
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase-A targeting probe for prostate cancer imaging and inhibition of metastasis.
Kim WY; Won M; Salimi A; Sharma A; Lim JH; Kwon SH; Jeon JY; Lee JY; Kim JS
Chem Commun (Camb); 2019 Oct; 55(88):13267-13270. PubMed ID: 31621760
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, optical properties and cytotoxicity of meso-heteroatom substituted IR-786 analogs.
Ma X; Laramie M; Henary M
Bioorg Med Chem Lett; 2018 Feb; 28(3):509-514. PubMed ID: 29249562
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
[TBL] [Abstract][Full Text] [Related]
10. Targeting monoamine oxidase A in advanced prostate cancer.
Flamand V; Zhao H; Peehl DM
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1761-71. PubMed ID: 20204405
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.
Han H; Li H; Ma Y; Zhao Z; An Q; Zhao J; Shi C
Cancer Lett; 2023 Jun; 563():216188. PubMed ID: 37076041
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
[TBL] [Abstract][Full Text] [Related]
13. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors.
Morales-Camilo N; Salas CO; Sanhueza C; Espinosa-Bustos C; Sepúlveda-Boza S; Reyes-Parada M; Gonzalez-Nilo F; Caroli-Rezende M; Fierro A
Chem Biol Drug Des; 2015 Jun; 85(6):685-95. PubMed ID: 25346162
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor structure-guided design and synthesis of near-infrared fluorescent probes for monoamine oxidase A (MAO-A) and its application in living cells and in vivo.
Yang Z; Li W; Chen H; Mo Q; Li J; Zhao S; Hou C; Qin J; Su G
Chem Commun (Camb); 2019 Feb; 55(17):2477-2480. PubMed ID: 30734773
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N'-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides.
Saddique FA; Zaib S; Jalil S; Aslam S; Ahmad M; Sultan S; Naz H; Iqbal M; Iqbal J
Eur J Med Chem; 2018 Jan; 143():1373-1386. PubMed ID: 29126721
[TBL] [Abstract][Full Text] [Related]
19. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]